-
Je něco špatně v tomto záznamu ?
Alterations in Outer Membrane Permeability Favor Drug-Resistant Phenotype of Klebsiella pneumoniae
L. Pulzova, L. Navratilova, L. Comor,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, přehledy
NLK
ProQuest Central
od 2000-06-01 do 2018-12-31
Health & Medicine (ProQuest)
od 2000-06-01 do 2018-12-31
Public Health Database (ProQuest)
od 2000-06-01 do 2018-12-31
PubMed
27526080
DOI
10.1089/mdr.2016.0017
Knihovny.cz E-zdroje
- MeSH
- antibakteriální látky farmakologie MeSH
- bakteriální proteiny genetika metabolismus MeSH
- biologický transport MeSH
- buněčná membrána účinky léků MeSH
- fenotyp MeSH
- geny MDR * MeSH
- infekce bakteriemi rodu Klebsiella farmakoterapie mikrobiologie přenos MeSH
- infekce spojené se zdravotní péčí farmakoterapie mikrobiologie přenos MeSH
- Klebsiella pneumoniae účinky léků genetika metabolismus MeSH
- lidé MeSH
- mnohočetná bakteriální léková rezistence genetika MeSH
- permeabilita buněčné membrány genetika MeSH
- poriny genetika metabolismus MeSH
- regulace genové exprese u bakterií * MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
The increasing number of infections caused by multidrug-resistant and pandrug-resistant bacteria represents a serious worlwide problem. Drug resistance limits available antimicrobials and can lead to suboptimal treatment of bacterial infections. It can be predicted that resistance to more antimicrobial drugs will be acquired by even more bacteria in the future. Among the distinct resistance strategies, preventing drug entrance to intracellular compartment through modification of membrane permeability (bacterial influx) and active export of compounds to the external environment (bacterial efflux) are of particular importance as they limit the interaction of the drug with its intracellular targets and, consequently, its deleterious effects on the cell. Several current studies have extended our understanding of drug resistance mechanisms associated with altered membrane permeability in gram-negative bacteria. In this study, we propose a summary of resistance mechanisms associated with transport of drugs across bacterial cell envelope exploited by Klebsiella pneumoniae, one of the most common nosocomial infection-causing pathogens. The better understanding of molecular bases of drug transport in/out of the single cell may have consequence for success in antimicrobial therapy of infection caused by drug-resistant Klebsiella.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18011066
- 003
- CZ-PrNML
- 005
- 20180426095544.0
- 007
- ta
- 008
- 180404s2017 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1089/mdr.2016.0017 $2 doi
- 035 __
- $a (PubMed)27526080
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Pulzova, Lucia $u 1 Laboratory of Biomedical Microbiology and Immunology, University of Veterinary Medicine and Pharmacy in Kosice , Kosice, Slovak Republic.
- 245 10
- $a Alterations in Outer Membrane Permeability Favor Drug-Resistant Phenotype of Klebsiella pneumoniae / $c L. Pulzova, L. Navratilova, L. Comor,
- 520 9_
- $a The increasing number of infections caused by multidrug-resistant and pandrug-resistant bacteria represents a serious worlwide problem. Drug resistance limits available antimicrobials and can lead to suboptimal treatment of bacterial infections. It can be predicted that resistance to more antimicrobial drugs will be acquired by even more bacteria in the future. Among the distinct resistance strategies, preventing drug entrance to intracellular compartment through modification of membrane permeability (bacterial influx) and active export of compounds to the external environment (bacterial efflux) are of particular importance as they limit the interaction of the drug with its intracellular targets and, consequently, its deleterious effects on the cell. Several current studies have extended our understanding of drug resistance mechanisms associated with altered membrane permeability in gram-negative bacteria. In this study, we propose a summary of resistance mechanisms associated with transport of drugs across bacterial cell envelope exploited by Klebsiella pneumoniae, one of the most common nosocomial infection-causing pathogens. The better understanding of molecular bases of drug transport in/out of the single cell may have consequence for success in antimicrobial therapy of infection caused by drug-resistant Klebsiella.
- 650 _2
- $a antibakteriální látky $x farmakologie $7 D000900
- 650 _2
- $a bakteriální proteiny $x genetika $x metabolismus $7 D001426
- 650 _2
- $a biologický transport $7 D001692
- 650 _2
- $a buněčná membrána $x účinky léků $7 D002462
- 650 _2
- $a permeabilita buněčné membrány $x genetika $7 D002463
- 650 _2
- $a infekce spojené se zdravotní péčí $x farmakoterapie $x mikrobiologie $x přenos $7 D003428
- 650 _2
- $a mnohočetná bakteriální léková rezistence $x genetika $7 D024901
- 650 12
- $a regulace genové exprese u bakterií $7 D015964
- 650 12
- $a geny MDR $7 D019450
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a infekce bakteriemi rodu Klebsiella $x farmakoterapie $x mikrobiologie $x přenos $7 D007710
- 650 _2
- $a Klebsiella pneumoniae $x účinky léků $x genetika $x metabolismus $7 D007711
- 650 _2
- $a fenotyp $7 D010641
- 650 _2
- $a poriny $x genetika $x metabolismus $7 D018272
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Navratilova, Lucie $u 2 Department of Microbiology, Faculty of Medicine and Dentistry, Palacky University , Olomouc, Czech Republic . 3 Laboratory of Growth Regulators, Institute of Experimental Botany AS CR, Palacky University , Olomouc, Czech Republic .
- 700 1_
- $a Comor, Lubos $u 1 Laboratory of Biomedical Microbiology and Immunology, University of Veterinary Medicine and Pharmacy in Kosice , Kosice, Slovak Republic.
- 773 0_
- $w MED00008749 $t Microbial drug resistance (Larchmont, N.Y.) $x 1931-8448 $g Roč. 23, č. 4 (2017), s. 413-420
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27526080 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180404 $b ABA008
- 991 __
- $a 20180426095654 $b ABA008
- 999 __
- $a ok $b bmc $g 1288551 $s 1007878
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 23 $c 4 $d 413-420 $e 20160815 $i 1931-8448 $m Microbial drug resistance $n Microb Drug Resist $x MED00008749
- LZP __
- $a Pubmed-20180404